Silihan lan utang jangka dawa perusahaan TFF Pharma (TFFP)

TFF Pharmaceuticals (TFFP) holds a unique patent for the creation of dry inhalation powders, demonstrating superiority in the field of materials science. The company monetizes its US developments through licensing agreements with global pharma behemoths. The current debt load is 0.00. This historical price chart illustrates the share price dynamics of this issuer.

Assessing the margin of safety for TFF Pharmaceuticals (TFFP) requires an analysis of its long-term liability structure. This metric aggregates all borrowings with a maturity of over one year, determining the issuer's overall credit leverage. By examining the TFF Pharmaceuticals (TFFP) long-term loans and borrowings chart, an investor can see the dynamics of financial pressure on capital. For this developer of thin-film freezing technologies, this indicator is critical when anticipating future royalties from pharma behemoths.